참고문헌
- Mosmann, T. R., H. Cherwinski, M. W. Bond, M. A. Giedlin, and R. L. Coffman. 2005. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J. Immunol. 175: 5-14.
- Park, H., Z. Li, X. O. Yang, S. H. Chang, R. Nurieva, Y. H. Wang, Y. Wang, L. Hood, Z. Zhu, Q. Tian, and C. Dong. 2005. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat. Immunol. 6: 1133-1141. https://doi.org/10.1038/ni1261
- Annunziato, F., L. Cosmi, V. Santarlasci, L. Maggi, F. Liotta, B. Mazzinghi, E. Parente, L. Fili, S. Ferri, F. Frosali, F. Giudici, P. Romagnani, P. Parronchi, F. Tonelli, E. Maggi, and S. Romagnani. 2007. Phenotypic and functional features of human Th17 cells. J. Exp. Med. 204: 1849-1861. https://doi.org/10.1084/jem.20070663
- Peck, A. and E. D. Mellins. 2009. Breaking old paradigms: Th17 cells in autoimmune arthritis. Clin. Immunol. 132: 295-304. https://doi.org/10.1016/j.clim.2009.03.522
- Sfanos, K. S., T. C. Bruno, C. H. Maris, L. Xu, C. J. Thoburn, A. M. DeMarzo, A. K. Meeker, W. B. Isaacs, and C. G. Drake. 2008. Phenotypic analysis of prostate-infiltrating lymphocytes reveals TH17 and Treg skewing. Clin. Cancer Res. 14: 3254-3261. https://doi.org/10.1158/1078-0432.CCR-07-5164
- Kryczek, I., S. Wei, L. Zou, S. Altuwaijri, W. Szeliga, J. Kolls, A. Chang, and W. Zou. 2007. Cutting edge: Th17 and regulatory T cell dynamics and the regulation by IL-2 in the tumor microenvironment. J. Immunol. 178: 6730-6733. https://doi.org/10.4049/jimmunol.178.11.6730
- Dong, C. 2008. TH17 cells in development: an updated view of their molecular identity and genetic programming. Nat. Rev. Immunol. 8: 337-348. https://doi.org/10.1038/nri2295
- Nam, J. S., M. Terabe, M. J. Kang, H. Chae, N. Voong, Y. A. Yang, A. Laurence, A. Michalowska, M. Mamura, S. Lonning, J. A. Berzofsky, and L. M. Wakefield. 2008. Transforming growth factor beta subverts the immune system into directly promoting tumor growth through interleukin-17. Cancer Res. 68: 3915-3923. https://doi.org/10.1158/0008-5472.CAN-08-0206
- Shime, H., M. Yabu, T. Akazawa, K. Kodama, M. Matsumoto, T. Seya, and N. Inoue. 2008. Tumor-secreted lactic acid promotes IL-23/IL-17 proinflammatory pathway. J. Immunol. 180: 7175-7183. https://doi.org/10.4049/jimmunol.180.11.7175
- Passos, S. T., J. S. Silver, A. C. O'Hara, D. Sehy, J. S. Stumhofer, and C. A. Hunter. 2010. IL-6 promotes NK cell production of IL-17 during toxoplasmosis. J. Immunol. 184: 1776-1783. https://doi.org/10.4049/jimmunol.0901843
- Mucida, D. and H. Cheroutre. 2007. TGFbeta and retinoic acid intersect in immune-regulation. Cell Adh. Migr. 1: 142-144. https://doi.org/10.4161/cam.1.3.5062
- Bettelli, E., T. Korn, M. Oukka, and V. K. Kuchroo. 2008. Induction and effector functions of T(H)17 cells. Nature 453: 1051-1057. https://doi.org/10.1038/nature07036
- Fossiez, F., O. Djossou, P. Chomarat, L. Flores-Romo, S. Ait-Yahia, C. Maat, J. J. Pin, P. Garrone, E. Garcia, S. Saeland, D. Blanchard, C. Gaillard, B. Das Mahapatra, E. Rouvier, P. Golstein, J. Banchereau, and S. Lebecque. 1996. T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines. J. Exp. Med. 183: 2593-2603. https://doi.org/10.1084/jem.183.6.2593
- Murugaiyan, G. and B. Saha. 2009. Protumor vs antitumor functions of IL-17. J. Immunol. 183: 4169-4175. https://doi.org/10.4049/jimmunol.0901017
- Zhang, B., G. Rong, H. Wei, M. Zhang, J. Bi, L. Ma, X. Xue, G. Wei, X. Liu, G. and Fang. 2008. The prevalence of Th17 cells in patients with gastric cancer. Biochem. Biophys. Res. Commun. 374: 533-537. https://doi.org/10.1016/j.bbrc.2008.07.060
- Honorati, M. C., S. Neri, L. Cattini, and A. Facchini. 2006. Interleukin-17, a regulator of angiogenic factor release by synovial fibroblasts1. Osteoarthritis Cartilage 14: 345-352. https://doi.org/10.1016/j.joca.2005.10.004
-
Jeon, S. H., B. C. Chae, H. A. Kim, G. Y. Seo, D. W. Seo, G. T. Chun, N. S. Kim, S. W. Yie, W. H. Byeon, S. H. Eom, K. S. Ha, Y. M. Kim, and P. H. Kim. 2007. Mechanisms underlying TGF-
${\beta}1$ -induced expression of VEGF and Flk-1 in mouse macrophages and their implications for angiogenesis. J. Leukoc. Biol. 81: 557-566. https://doi.org/10.1189/jlb.0806517 - Wang, L., T. Yi, M. Kortylewski, D. M. Pardoll, D. Zeng, and H. Yu. 2009. IL-17 can promote tumor growth through an IL-6-Stat3 signaling pathway. J. Exp. Med. 206: 1457-1464. https://doi.org/10.1084/jem.20090207
- Radosavljevic, G., B. Ljujic, I. Jovanovic, Z. Srzentic, S. Pavlovic, N. Zdravkovic, M. Milovanovic, D. Bankovic, M. Knezevic, L. J. Acimovic, and N. Arsenijevic. 2010. Interleukin-17 may be a valuable serum tumor marker in patients with colorectal carcinoma. Neoplasma 57: 135-144. https://doi.org/10.4149/neo_2010_02_135
- Jovanovic, D. V., J. A. Di Battista, J. Martel-Pelletier, F. C. Jolicoeur, Y. He, M. Zhang, F. Mineau, and J. P. Pelletier. 1998. IL-17 stimulates the production and expression of proinflammatory cytokines, IL-beta and TNF-alpha, by human macrophages. J. Immunol. 160: 3513-3521.
- Muranski, P., A. Boni, P. A. Antony, L. Cassard, K. R. Irvine, A. Kaiser, C. M. Paulos, D. C. Palmer, C. E. Touloukian, K. Ptak, L. Gattinoni, C. Wrzesinski, C. S. Hinrichs, K. W. Kerstann, L. Feigenbaum, C. C. Chan, and N. P. Restifo. 2008. Tumor-specific Th17-polarized cells eradicate large established melanoma. Blood 112: 362-373. https://doi.org/10.1182/blood-2007-11-120998
- Ankathatti Munegowda M, Deng Y, Mulligan SJ, and Xiang J. 2011. Th17 and Th17-stimulated CD8+ T cells play a distinct role in Th17-induced preventive and therapeutic antitumor immunity. Cancer Immunol. Immunother. 60: 1473-1484. https://doi.org/10.1007/s00262-011-1054-y
- Kolahdoozan S, Sadjadi A, Radmard AR, and Khademi H. 2010. Five common cancers in Iran. Arch. Iran. Med. 13: 143-146.
- Zhang, J. P., J. Yan, J. Xu, X. H. Pang, M. S. Chen, L. Li, C. Wu, S. P. Li, and L. Zheng. 2009. Increased intratumoral IL-17-producing cells correlate with poor survival in hepatocellular carcinoma patients. J. Hepatol. 50: 980-989. https://doi.org/10.1016/j.jhep.2008.12.033
- Zhang, B., G. Rong, H. Wei, M. Zhang, J. Bi, L. Ma, X. Xue, G. Wei, X. Liu, and G. Fang. 2008. The prevalence of Th17 cells in patients with gastric cancer. Biochem. Biophys. Res. Commun. 374: 533-537. https://doi.org/10.1016/j.bbrc.2008.07.060
- Zhu, X., L. A. Mulcahy, R. A. Mohammed, A. H. Lee, H. A. Franks, L. Kilpatrick, A. Yilmazer, E. C. Paish, I. O. Ellis, P. M. Patel, and A. M. Jackson. 2008. IL-17 expression by breast-cancer-associated macrophages: IL-17 promotes invasiveness of breast cancer cell lines. Breast Cancer Res. 10: R95. https://doi.org/10.1186/bcr2195
- Kato, T., H. Furumoto, T. Ogura, Y. Onishi, M. Irahara, S. Yamano, M. Kamada, and T. Aono. 2001. Expression of IL-17 mRNA in ovarian cancer. Biochem. Biophys. Res. Commun. 282: 735-738. https://doi.org/10.1006/bbrc.2001.4618
- Chi, L. J., H. T. Lu, G. L. Li, X. M. Wang, Y. Su, W. H. Xu, and B. Z. Shen. 2010. Involvement of T helper type 17 and regulatory T cell activity in tumour immunology of bladder carcinoma. Clin. Exp. Immunol. 161: 480-489. https://doi.org/10.1111/j.1365-2249.2010.04215.x
-
Lee, J. J., Y. L. Chang, W. L. Lai, J. Y. Ko, M. Y. Kuo, C. P. Chiang, M. Azuma, C. W. Chen, and J. S. Chia. 2011. Increased prevalence of interleukin-17-producing
$CD4^+$ tumor infiltrating lymphocytes in human oral squamous cell carcinoma. Head Neck 33: 1301-1308. https://doi.org/10.1002/hed.21607 - Kwon, K. A., S. H. Kim, S. Y. Oh, S. Lee, J. Y. Han, K. H. Kim, R. Y. Goh, H. J. Choi, K. J. Park, M. S. Roh, H. J. Kim, H. C. Kwon, and J. H. Lee. 2010. Clinical significance of preoperative serum vascular endothelial growth factor, interleukin-6, and C-reactive protein level in colorectal cancer. BMC Cancer 10: 203. https://doi.org/10.1186/1471-2407-10-203
- Ravishankaran, P. and R. Karunanithi. 2011. Clinical significance of preoperative serum interleukin-6 and C-reactive protein level in breast cancer patients. World J. Surg. Oncol. 9: 18. https://doi.org/10.1186/1477-7819-9-18
- Chen, M. F., P. Y. Lin, C. F. Wu, W. C. Chen, and C. T. Wu. 2013. IL-6 expression regulates tumorigenicity and correlates with prognosis in bladder cancer. PLoS One 8: e61901. https://doi.org/10.1371/journal.pone.0061901
- Yang, L., Y. Qi, J. Hu, L. Tang, S. Zhao, and B. Shan. 2012. Expression of Th17 cells in breast cancer tissue and its association with clinical parameters. Cell Biochem. Biophys. 62: 153-159. https://doi.org/10.1007/s12013-011-9276-3
- Weaver, C. T. and R. D. Hatton. 2009. Interplay between the TH17 and TReg cell lineages: a (co-) evolutionary perspective. Nat. Rev. Immunol. 9: 883-889. https://doi.org/10.1038/nri2660
- Khatami, M. 2009. Inflammation, aging, and cancer: tumoricidal versus tumorigenesis of immunity: a common denominator mapping chronic diseases. Cell Biochem. Biophys. 55: 55-79. https://doi.org/10.1007/s12013-009-9059-2
- Erdman, S. E. and T. Poutahidis. 2010. Roles for inflammation and regulatory T cells in colon cancer. Toxicol. Pathol. 38: 76-87. https://doi.org/10.1177/0192623309354110
- Connolly, E. C., J. Freimuth, and R. J. Akhurst. 2012. Complexities of TGF-beta Targeted Cancer Therapy. Int. J. Biol. Sci. 8: 964-978. https://doi.org/10.7150/ijbs.4564
피인용 문헌
- Inhibition of Tumor Growth and Immunomodulatory Effects of Flavonoids and Scutebarbatines of Scutellaria barbata D. Don in Lewis-Bearing C57BL/6 Mice vol.2015, pp.None, 2014, https://doi.org/10.1155/2015/630760
- Urothelial Cancer: Inflammatory Mediators and Implications for Immunotherapy vol.30, pp.4, 2014, https://doi.org/10.1007/s40259-016-0176-3
- Immune analysis of expression of IL-17 relative ligands and their receptors in bladder cancer: comparison with polyp and cystitis vol.17, pp.None, 2014, https://doi.org/10.1186/s12865-016-0174-8
- Survival Rate of Patients with Bladder Cancer in Yazd, Central Province of Iran vol.11, pp.5, 2014, https://doi.org/10.5812/ijcm.61436
- TGF-β and microRNA Interplay in Genitourinary Cancers vol.8, pp.12, 2014, https://doi.org/10.3390/cells8121619
- The Interplay between Oxidative Stress, Inflammation and Angiogenesis in Bladder Cancer Development vol.22, pp.9, 2021, https://doi.org/10.3390/ijms22094483
- The inflammatory microenvironment and the urinary microbiome in the initiation and progression of bladder cancer vol.8, pp.6, 2014, https://doi.org/10.1016/j.gendis.2020.10.002
- Overexpressed pseudogene MT1L associated with tumor immune infiltrates and indicates a worse prognosis in BLCA vol.19, pp.1, 2014, https://doi.org/10.1186/s12957-021-02231-4